BTS
CVS icon

BB&T Securities’s CVS Health CVS Stock Holding History

BB&T Securities’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$86.3M Sell
1,368,498
-29,283
-2% -$1.74M 0.79% 19
2019
Q2 		$76.2M Buy
1,397,781
+223,633
+19% +$12M 0.69% 21
2019
Q1 		$63.3M Buy
1,174,148
+197,389
+20% +$12.2M 0.61% 31
2018
Q4 		$64M Buy
976,759
+68,675
+8% +$5.13M 0.71% 20
2018
Q3 		$71.5M Buy
908,084
+117,301
+15% +$8.39M 0.7% 20
2018
Q2 		$50.9M Buy
790,783
+69,723
+10% +$4.59M 0.54% 36
2018
Q1 		$44.9M Buy
721,060
+193,511
+37% +$13.9M 0.51% 39
2017
Q4 		$38.2M Buy
527,549
+12,105
+2% +$880K 0.5% 38
2017
Q3 		$41.9M Buy
515,444
+21,161
+4% +$1.67M 0.57% 33
2017
Q2 		$39.8M Sell
494,283
-103,773
-17% -$8.19M 0.58% 32
2017
Q1 		$46.9M Buy
598,056
+331,379
+124% +$26.5M 0.64% 30
2016
Q4 		$22.4M Buy
266,677
+44,220
+20% +$3.58M 0.33% 81
2016
Q3 		$19.8M Sell
222,457
-76,867
-26% -$7.26M 0.29% 93
2016
Q2 		$28.7M Buy
299,324
+6,368
+2% +$635K 0.44% 62
2016
Q1 		$30.4M Buy
292,956
+203,350
+227% +$19.8M 0.5% 56
2015
Q4 		$8.76M Sell
89,606
-11,959
-12% -$1.17M 0.18% 122
2015
Q3 		$9.8M Sell
101,565
-2,903
-3% -$305K 0.22% 101
2015
Q2 		$11M Buy
104,468
+92
+0.1% +$9.4K 0.23% 95
2015
Q1 		$10.8M Buy
104,376
+11,786
+13% +$1.19M 0.24% 95
2014
Q4 		$8.92M Buy
92,590
+26,038
+39% +$2.29M 0.2% 107
2014
Q3 		$5.3M Buy
66,552
+7,558
+13% +$596K 0.12% 155
2014
Q2 		$4.45M Sell
58,994
-9,057
-13% -$684K 0.11% 170
2014
Q1 		$5.09M Sell
68,051
-1,526
-2% -$108K 0.13% 133
2013
Q4 		$4.98M Buy
69,577
+44,942
+182% +$2.89M 0.14% 133
2013
Q3 		$1.4M Buy
24,635
+3,537
+17% +$211K 0.04% 284
2013
Q2 		$1.21M Buy
+21,098
New +$1.22M 0.04% 294

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BB&T Securities's CVS Position: Q3 2019 in Review

BB&T Securities reduced its CVS Health (CVS) stake by 2.1% in Q3 2019, selling an estimated $1.74M and leaving 1,368,498 shares worth $86.3M. The position accounts for 0.79% of the portfolio, ranked #19.

BB&T Securities first reported a position in CVS in Q2 2013 and has held it in 26 quarters since. 1,684 funds tracked by Wall St. Rank hold CVS as of Q3 2019.

  • BB&T Securities held 1,368,498 shares of CVS Health worth $86.3M as of Q3 2019.
  • BB&T Securities sold 29,283 CVS Health shares in Q3 2019, an estimated $1.74M.
  • CVS Health made up 0.79% of BB&T Securities's portfolio in Q3 2019, its #19 holding.
  • BB&T Securities first reported a position in CVS Health in Q2 2013 and has held it in 26 quarters since.
  • 1,684 funds tracked by Wall St. Rank held CVS Health as of Q3 2019.

Based on BB&T Securities's 13F filing for Q3 2019, filed 30 Oct 2019.